Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia

• Status: Completed
• Trial end date: 2003-03-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a research study comparing the safety and efficacy of two active study medications

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Eli Lilly and Company
• Treatments: Olanzapine; Ziprasidone

Criteria

Inclusion Criteria:

• Male or female subjects 18-60 years of age

• Female subjects of childbearing potential must be using a medically accepted means of contraception

• Each subject must have a level of understanding sufficient to perform all tests and examinations required by the protocol

• Subjects must be considered reliable

Exclusion Criteria:

• Treatment with a drug within the last 30 days that has not received regulatory approval at the time of study entry

• Female subjects who are either pregnant or nursing

• Uncorrected hypothyroidism or hyperthyroidism

• Narrow-angle glaucoma